INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

Contents
Consolidated Statements of Income - unaudited	12
Consolidated Statements of Comprehensive Income - unaudited	12
Consolidated Balance Sheets - unaudited	13
Consolidated Statements of Changes in Shareholders' Equity - unaudited	14
Consolidated Statements of Cash Flows - unaudited	16
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
Note 1 - Basis of presentation	17
Note 2 - Recent accounting pronouncements	17
Note 3 - Acquisition	18
Note 4 - Assets held for sale	19
Note 5 - Revenues	20
Note 6 - Pensions and other postretirement benefits	21
Note 7 - Earnings per share	21
Note 8 - Financing activities	22
Note 9 - Stock-based compensation	24
Note 10 - Accumulated other comprehensive loss	26
Note 11 - Major commitments and contingencies	28
Note 12 - Financial instruments	29
Note 13 - Segmented information	31

CN | 2025 Quarterly Review – Third Quarter 11

CONSOLIDATED STATEMENTS OF INCOME – UNAUDITED

	Three months ended September 30				Nine months ended September 30
In millions, except per share data	2025		2024		2025		2024
Revenues (Note 5)	$	4,165	$	4,110	$	12,840	$	12,688
Operating expenses
Labor and fringe benefits	815		795		2,597		2,539
Purchased services and material	562		566		1,715		1,715
Fuel	418		519		1,349		1,579
Depreciation and amortization	500		475		1,482		1,403
Equipment rents	103		93		326		294
Other	161		147		517		461
Loss on assets held for sale (Note 4)	—		—		—		78
Total operating expenses	2,559		2,595		7,986		8,069
Operating income	1,606		1,515		4,854		4,619
Interest expense	(227)		(230)		(679)		(660)
Other components of net periodic benefit income (Note 6)	125		114		376		341
Other income	3		10		44		44
Income before income taxes	1,507		1,409		4,595		4,344
Income tax expense	(368)		(324)		(1,123)		(1,042)
Net income	$	1,139	$	1,085	$	3,472	$	3,302
Earnings per share (Note 7)
Basic	$	1.83	$	1.72	$	5.55	$	5.20
Diluted	$	1.83	$	1.72	$	5.54	$	5.19
Weighted-average number of shares (Note 7)
Basic	621.9		629.6		625.7		635.1
Diluted	622.4		630.5		626.2		636.2
Dividends declared per share	$	0.8875	$	0.8450	$	2.6625	$	2.5350

See accompanying notes to Interim Consolidated Financial Statements.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME – UNAUDITED

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Net income	$	1,139	$	1,085	$	3,472	$	3,302
Other comprehensive income (loss) (Note 10)
Net gain (loss) on foreign currency translation	137		(53)		(208)		95
Net change in pension and other postretirement benefit plans (Note 6)	13		12		36		39
Derivative instruments (Note 12)	(3)		(16)		—		(19)
Other comprehensive income (loss) before income taxes	147		(57)		(172)		115
Income tax recovery (expense)	31		(17)		(59)		26
Other comprehensive income (loss)	178		(74)		(231)		141
Comprehensive income	$	1,317	$	1,011	$	3,241	$	3,443

See accompanying notes to Interim Consolidated Financial Statements.

12CN| 2025 Quarterly Review – Third Quarter

CONSOLIDATED BALANCE SHEETS – UNAUDITED

		September 30		December 31
In millions	As at	2025		2024
Assets
Current assets
Cash and cash equivalents		$	214	$	389
Restricted cash and cash equivalents		12		12
Accounts receivable		1,246		1,164
Material and supplies		780		720
Other current assets		260		334
Total current assets		2,512		2,619
Properties		48,668		47,960
Operating lease right-of-use assets		461		485
Pension asset		4,882		4,541
Deferred income tax assets		631		689
Intangible assets, goodwill and other		500		773
Total assets		$	57,654	$	57,067
Liabilities and shareholders' equity
Current liabilities
Accounts payable and other		$	2,607	$	2,810
Current portion of long-term debt		1,566		1,166
Total current liabilities		4,173		3,976
Deferred income tax liabilities		11,040		10,874
Other liabilities and deferred credits		805		612
Pension and other postretirement benefits		470		483
Long-term debt		19,554		19,728
Operating lease liabilities		339		343
Total liabilities		36,381		36,016
Shareholders' equity
Common shares		3,468		3,474
Common shares in Share Trusts		(137)		(129)
Additional paid-in capital		404		372
Accumulated other comprehensive loss (Note 10)		(1,251)		(1,020)
Retained earnings		18,789		18,354
Total shareholders' equity		21,273		21,051
Total liabilities and shareholders' equity		$	57,654	$	57,067

See accompanying notes to Interim Consolidated Financial Statements.

CN | 2025 Quarterly Review – Third Quarter 13

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED

	Number of common shares		Common shares		Common shares in Share Trusts		Additional paid-in capital		Accumulated other comprehensive loss		Retained earnings		Total shareholders' equity
In millions	Outstanding	Share Trusts
Balance at June 30, 2025	625.4	0.9	$	3,510	$	(134)	$	389	$	(1,429)	$	19,200	$	21,536
Net income											1,139		1,139
Stock options exercised	0.1		2				—						2
Settlement of equity settled awards	—	—			8		(9)				(2)		(3)
Stock-based compensation and other							24				(1)		23
Repurchase of common shares (Note 8)	(7.7)		(44)								(997)		(1,041)
Share purchases by Share Trusts	(0.1)	0.1			(11)								(11)
Other comprehensive income (Note 10)									178				178
Dividends											(550)		(550)
Balance at September 30, 2025	617.7	1.0	$	3,468	$	(137)	$	404	$	(1,251)	$	18,789	$	21,273

	Number of common shares		Common shares		Common shares in Share Trusts		Additional paid-in capital		Accumulated other comprehensive loss		Retained earnings		Total shareholders' equity
In millions	Outstanding	Share Trusts
Balance at December 31, 2024	627.9	0.9	$	3,474	$	(129)	$	372	$	(1,020)	$	18,354	$	21,051
Net income											3,472		3,472
Stock options exercised	0.4		53				(7)						46
Settlement of equity settled awards	0.1	(0.1)			24		(54)				19		(11)
Stock-based compensation and other							93				(4)		89
Repurchase of common shares (Note 8)	(10.5)		(59)								(1,389)		(1,448)
Share purchases by Share Trusts	(0.2)	0.2			(32)								(32)
Other comprehensive loss (Note 10)									(231)				(231)
Dividends											(1,663)		(1,663)
Balance at September 30, 2025	617.7	1.0	$	3,468	$	(137)	$	404	$	(1,251)	$	18,789	$	21,273

See accompanying notes to Interim Consolidated Financial Statements.

14CN| 2025 Quarterly Review – Third Quarter

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED

	Number of common shares		Common shares		Common shares in Share Trusts		Additional paid-in capital		Accumulated other comprehensive loss		Retained earnings		Total shareholders' equity
In millions	Outstanding	Share Trusts
Balance at June 30, 2024	631.3	0.9	$	3,484	$	(129)	$	364	$	(2,064)	$	17,749	$	19,404
Net income											1,085		1,085
Stock options exercised	0.1		7				(1)						6
Settlement of equity settled awards	—	—			8		(9)				(1)		(2)
Stock-based compensation and other							6				(1)		5
Repurchase of common shares (Note 8)	(2.5)		(14)								(413)		(427)
Share purchases by Share Trusts	(0.1)	0.1			(7)								(7)
Other comprehensive loss (Note 10)									(74)				(74)
Dividends											(532)		(532)
Balance at September 30, 2024	628.8	1.0	$	3,477	$	(128)	$	360	$	(2,138)	$	17,887	$	19,458

	Number of common shares		Common shares		Common shares in Share Trusts		Additional paid-in capital		Accumulated other comprehensive loss		Retained earnings		Total shareholders' equity
In millions	Outstanding	Share Trusts
Balance at December 31, 2023	642.7	1.1	$	3,512	$	(144)	$	373	$	(2,279)	$	18,655	$	20,117
Net income											3,302		3,302
Stock options exercised	0.4		44				(6)						38
Settlement of equity settled awards	0.4	(0.4)			58		(73)				(42)		(57)
Stock-based compensation and other							66				(2)		64
Repurchase of common shares (Note 8)	(14.4)		(79)								(2,419)		(2,498)
Share purchases by Share Trusts	(0.3)	0.3			(42)								(42)
Other comprehensive income (Note 10)									141				141
Dividends											(1,607)		(1,607)
Balance at September 30, 2024	628.8	1.0	$	3,477	$	(128)	$	360	$	(2,138)	$	17,887	$	19,458

See accompanying notes to Interim Consolidated Financial Statements.

CN | 2025 Quarterly Review – Third Quarter 15

CONSOLIDATED STATEMENTS OF CASH FLOWS – UNAUDITED

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Operating activities
Net income	$	1,139	$	1,085	$	3,472	$	3,302
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	500		475		1,482		1,403
Pension income and funding	(101)		(95)		(305)		(288)
Deferred income taxes	92		152		190		307
Loss on assets held for sale (Note 4)	—		—		—		78
Changes in operating assets and liabilities:
Accounts receivable	(83)		(5)		(40)		73
Material and supplies	43		59		(67)		(23)
Accounts payable and other	233		1		71		(288)
Other current assets	12		70		(113)		(23)
Other operating activities, net	78		32		132		163
Net cash provided by operating activities	1,913		1,774		4,822		4,704
Investing activities
Property additions	(1,105)		(1,176)		(2,429)		(2,605)
Other investing activities, net	(15)		(14)		(52)		(39)
Net cash used in investing activities	(1,120)		(1,190)		(2,481)		(2,644)
Financing activities
Issuance of debt (Note 8)	—		1,011		995		3,117
Repayment of debt	(371)		(17)		(420)		(528)
Change in commercial paper, net (Note 8)	719		(675)		26		(756)
Settlement of foreign exchange forward contracts on debt	33		(15)		17		(2)
Issuance of common shares for stock options exercised	2		6		46		38
Withholding taxes remitted on the net settlement of equity settled awards (Note 9)	(2)		(1)		(7)		(52)
Repurchase of common shares	(1,028)		(438)		(1,472)		(2,450)
Purchase of common shares for settlement of equity settled awards	(1)		(1)		(4)		(5)
Purchase of common shares by Share Trusts	(11)		(7)		(32)		(42)
Dividends paid	(550)		(532)		(1,663)		(1,607)
Net cash used in financing activities	(1,209)		(669)		(2,514)		(2,287)
Effect of foreign exchange fluctuations on cash, cash equivalents, restricted cash and restricted cash equivalents	2		(1)		(2)		1
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	(414)		(86)		(175)		(226)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	640		784		401		924
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$	226	$	698	$	226	$	698
Cash and cash equivalents, end of period	$	214	$	273	$	214	$	273
Restricted cash and cash equivalents, end of period	12		425		12		425
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$	226	$	698	$	226	$	698
Supplemental cash flow information
Interest paid	$	(279)	$	(265)	$	(763)	$	(716)
Income taxes paid	$	(231)	$	(262)	$	(708)	$	(933)

See accompanying notes to Interim Consolidated Financial Statements.

16 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

1 – Basis of presentation

In these notes, the "Company" or "CN" refers to Canadian National Railway Company, together with its wholly-owned subsidiaries. The accompanying unaudited Interim Consolidated Financial Statements ("Interim Consolidated Financial Statements"), expressed in Canadian dollars, have been prepared in accordance with United States generally accepted accounting principles (GAAP) for interim financial statements. Accordingly, they do not include all of the disclosures required by GAAP for complete financial statements. In management's opinion, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. Interim operating results are not necessarily indicative of the results that may be expected for the full year.

These Interim Consolidated Financial Statements have been prepared using accounting policies consistent with those used in preparing CN's 2024 Annual Consolidated Financial Statements and should be read in conjunction with such statements and Notes thereto.

2 – Recent accounting pronouncements

The following recent Accounting Standards Updates (ASU) issued by the Financial Accounting Standards Board (FASB) have an effective date after December 31, 2024 and have not been adopted by the Company:

ASU 2025-06 – Intangibles - Goodwill and Other Internal-Use Software (Subtopic 350-40)

This ASU modernizes the accounting for internal-use software by removing references to prescriptive and sequential software development stages. The main provisions establish that capitalization begins when management authorizes and commits to funding the software project and it is probable the project will be completed and used as intended. The ASU also introduces enhanced disclosure requirements that align internal-use software disclosures to property, plant and equipment. It also consolidates guidance for website development by integrating it into the framework for internal-use software.

The amendments in this ASU are effective for annual periods beginning after December 15, 2027, including interim periods within these fiscal years. Early adoption is permitted. The amendments in this ASU must be adopted either prospectively, retrospectively or using a modified transition approach based on project status and prior capitalization.

The Company is evaluating the effects that the adoption of the ASU will have on its Consolidated Financial Statements and disclosures.

ASU 2025-05 – Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

This ASU introduces an optional practical expedient to simplify the estimation of expected credit losses on current trade receivables and current contract assets arising from revenue transactions. When elected, an entity may assume that current conditions at the balance sheet date will remain unchanged over the remaining life of the assets in developing its reasonable and supportable forecast; entities still adjust historical loss information to reflect current conditions, but they need not incorporate forward-looking macroeconomic forecasts for assets within scope.

The amendments in this ASU are effective for annual periods beginning after December 15, 2025, including interim periods within these fiscal years. Early adoption is permitted. The amendments in this ASU should be applied prospectively to Consolidated Financial Statements.

The Company is evaluating the effects that the adoption of the ASU will have on its Consolidated Financial Statements and disclosures and is considering whether to adopt the practical expedient.

CN| 2025 Quarterly Review – Third Quarter 17

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

ASU 2024-03 – Disaggregation of Income Statement Expenses (Subtopic 220-40)

This ASU aims to provide stakeholders a clearer understanding of an entity's expenses and enhance their ability to assess performance, forecast expenses and evaluate the entity's potential for future cash flows. The ASU amends the rules on income statement expense disclosures and requires public business entities to disaggregate and disclose, in tabular format in the notes to financial statements, specified categories of expenses contained within certain income statement expense line items; to integrate certain amounts that were already required to be disclosed under current GAAP with the new disaggregation requirements and to qualitatively disclose descriptions of the amounts remaining that were not separately disaggregated. The ASU also requires public business entities to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of those selling expenses. This ASU does not change or remove the current disclosure requirements of expense line items on the face of the Consolidated Statements of Income.

The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU should be applied either prospectively to Consolidated Financial Statements issued for reporting periods following the effective date, or retrospectively to any or all prior periods presented in the Consolidated Financial Statements.

The Company is evaluating the effects that the adoption of the ASU will have on its Consolidated Financial Statements disclosures.

ASU 2023-09 – Income Taxes (Topic 740): Improvements to Income Tax Disclosures

The ASU amends the rules on income tax disclosures by modifying or eliminating certain existing income tax disclosure requirements in addition to establishing new requirements. The amendments address investor requests for more transparency about income taxes, including jurisdictional information, by requiring consistent categories and greater disaggregation of information. The ASU’s two primary amendments relate to the rate reconciliation and income taxes paid annual disclosures.

Reconciling items presented in the rate reconciliation will be in dollar amounts and percentages, and will be disaggregated into specified categories with certain reconciling items further broken out by nature and/or jurisdiction using a 5% threshold of domestic federal taxes. Income taxes paid will be disaggregated between federal, provincial/territorial, and foreign taxing jurisdictions using a 5% threshold of total income taxes paid net of refunds received.

The ASU is effective for annual periods beginning after December 15, 2024. The adoption of the ASU will impact the Company’s Annual Consolidated Financial Statement disclosures. The Company will adopt the ASU in the fourth quarter of 2025 and will reflect the relevant annual disclosure changes prospectively, including the disaggregation of rate reconciliation items and income tax payments by specified categories, nature and/or jurisdiction as described above.

Other recently issued ASUs required to be applied on or after September 30, 2025 have been evaluated by the Company and are not expected to have a significant impact on the Company's Consolidated Financial Statements.

3 – Acquisition

On January 14, 2025, the Surface Transportation Board (STB) issued a final decision approving CN’s application to acquire control of the Iowa Northern Railway Company (IANR), subject to certain conditions. The Company assumed control of IANR on March 1, 2025 (Control Date) and began consolidating IANR on that date, accounting for the acquisition as a business combination achieved in stages. The Company derecognized its previously held equity method investment in IANR of $320 million as of March 1, 2025 and remeasured the investment at its Control Date fair value of $344 million resulting in a net remeasurement gain of $24 million recorded in Other income in the Consolidated Statements of Income. The fair value of the previously held equity interest in IANR was determined through use of a discounted cash flow approach, which incorporated the Company’s best estimates of various assumptions including, but not limited to, discount rates and terminal growth rates and multiples.

The Company's Consolidated Balance Sheet includes the assets and liabilities of IANR as of the Control Date, and since that time, IANR’s results of operations have been included in the Company's results of operations. The Company has not provided pro forma information relating to the pre-control date period as the acquisition was not material.

18 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

The following table summarizes the preliminary purchase price allocation with the fair value at the Control Date of the previously held equity interest in IANR, as well as the amounts recognized for the identifiable assets acquired and liabilities assumed on the Control Date:

(in millions)	March 1, 2025
Consideration
Fair value of previously held equity method investment (1)	$	344
Recognized amounts of identifiable assets acquired and liabilities assumed (1)
Current assets	$	10
Properties	425
Other non-current assets	12
Current liabilities	(20)
Deferred income tax liabilities	(93)
Other non-current liabilities	(23)
Total identifiable net assets (2)	$	311
Goodwill (3)	$	33

(1)The Company's fair value of the previously held equity interest in IANR and the related purchase price allocation is preliminary based on information available to the Company to date and subject to change over the measurement period, which may be up to one year from the Control Date.

(2)Includes operating lease right-of-use assets and liabilities. There were no identifiable intangible assets.

(3)The goodwill acquired through the business combination is mainly attributable to the premium of an established business operation. The goodwill is not deductible for tax purposes.

The preliminary fair values of Properties were determined using valuation techniques including the market approach and the cost approach. The significant assumptions used to determine the preliminary fair value of Properties were mostly related to a selection of comparable assets and inflation.

4 – Assets held for sale

On May 8, 2024, CN entered into an agreement to transfer the ownership and related risks and obligations of a road, rail, and pedestrian bridge known as the Quebec Bridge located in Quebec, Canada, to the Government of Canada for a nominal amount. At that time, CN met the criteria for classification of the related track and roadway assets as assets held for sale and accordingly recorded a loss of $78 million ($58 million after-tax) to adjust the carrying value to the nominal selling price. On November 12, 2024, the transaction was completed and the resulting difference between the carrying value and what was estimated was insignificant. CN had also recognized an operating lease right-of-use asset and a related liability of $124 million for the retained requisite rights to occupy and operate the portion of the bridge where the rail infrastructure is located and will pay an annual occupancy fee over a term that also includes a noncancellable period.

CN| 2025 Quarterly Review – Third Quarter 19

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

5 – Revenues

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Freight revenues
Petroleum and chemicals	$	854	$	839	$	2,577	$	2,546
Metals and minerals	477		502		1,496		1,560
Forest products	451		467		1,406		1,462
Coal	237		229		725		691
Grain and fertilizers	775		786		2,560		2,384
Intermodal	980		882		2,928		2,881
Automotive	217		217		677		688
Total freight revenues	3,991		3,922		12,369		12,212
Other revenues	174		188		471		476
Total revenues (1)	$	4,165	$	4,110	$	12,840	$	12,688
Revenues by geographic area
Canada	$	2,887	$	2,825	$	8,946	$	8,832
United States (U.S.)	1,278		1,285		3,894		3,856
Total revenues (1)	$	4,165	$	4,110	$	12,840	$	12,688

(1)As at September 30, 2025, the Company had remaining performance obligations related to freight in-transit, for which revenues of $96 million ($80million as at September 30, 2024) are expected to be recognized in the next quarterly period.

Contract liabilities

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Beginning balance	$	317	$	104	$	191	$	95
Revenue recognized included in the beginning balance	(9)		(7)		(13)		(14)
Increase due to consideration received, net of revenue recognized	76		56		206		72
Ending balance	$	384	$	153	$	384	$	153
Current portion - Ending balance	$	8	$	6	$	8	$	6

20 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

6 – Pensions and other postretirement benefits

The Company has various retirement benefit plans under which substantially all of its employees are entitled to benefits at retirement age, generally based on compensation and length of service and/or contributions. Additional information relating to the retirement benefit plans is provided in Note 17 – Pensions and other postretirement benefits to the Company's 2024 Annual Consolidated Financial Statements.

	Three months ended September 30								Nine months ended September 30
	Pensions				Other postretirement benefits				Pensions				Other postretirement benefits
In millions	2025		2024		2025		2024		2025		2024		2025		2024
Current service cost	$	21	$	23	$	1	$	1	$	63	$	69	$	1	$	1
Other components of net periodic benefit income:
Interest cost	150		168		2		2		453		502		5		5
Expected return on plan assets	(290)		(296)		—		—		(870)		(887)		—		—
Amortization of prior service credit	—		—		(1)		(2)		—		—		(3)		(3)
Amortization of net actuarial loss (gain)	15		16		(1)		(2)		43		47		(4)		(5)
Total Other components of net periodic benefit income	(125)		(112)		—		(2)		(374)		(338)		(2)		(3)
Net periodic benefit income (1)	$	(104)	$	(89)	$	1	$	(1)	$	(311)	$	(269)	$	(1)	$	(2)

(1)In the second quarters of 2025 and 2024, the Company revised its estimate of full year net periodic benefit income for pensions to reflect updated plan demographic information and the resulting impacts were not significant.

Pension contributions

Pension contributions for all plans for the nine months ended September 30, 2025 and 2024 were $57 million and $51 million, respectively. During the first quarter of 2025, one of CN's Canadian defined contribution pension plans was merged into the CN Pension Plan, and did not result in a remeasurement of the funded status of that plan. Based on the results of the Company's actuarial valuations for funding purposes as at December 31, 2024, the CN Pension Plan remained fully funded and at a level such that the Company continues to be prohibited from making contributions to the defined benefit component of the CN Pension Plan. As such, total cash contributions of approximately $70 million are expected to be made in 2025 for all pension plans other than the defined benefit component of the CN Pension Plan.

7 – Earnings per share

	Three months ended September 30				Nine months ended September 30
In millions, except per share data	2025		2024		2025		2024
Net income	$	1,139	$	1,085	$	3,472	$	3,302
Weighted-average basic shares outstanding	621.9		629.6		625.7		635.1
Dilutive effect of stock-based compensation	0.5		0.9		0.5		1.1
Weighted-average diluted shares outstanding	622.4		630.5		626.2		636.2
Basic earnings per share	$	1.83	$	1.72	$	5.55	$	5.20
Diluted earnings per share	$	1.83	$	1.72	$	5.54	$	5.19
Units excluded from the calculation as their inclusion would not have a dilutive effect
Stock options	2.5		1.4		2.1		1.2
Performance share units	0.7		0.6		0.7		0.3

CN| 2025 Quarterly Review – Third Quarter 21

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

8 – Financing activities

For details on the Company's available financing sources, see Note 15 – Debt to the Company's 2024 Annual Consolidated Financial Statements. For the nine months ended September 30, 2025, the following changes occurred:

Notes and debentures

For the nine months ended September 30, 2025, the Company issued and repaid the following:

•On September 22, 2025, repayment of $350 million 2.80% Notes due 2025 upon maturity; and

•On June 10, 2025, issuance of $500 million 3.50% Notes due 2030 and $500 million 4.20% Notes due 2035 in the Canadian capital markets, which resulted in total net proceeds of $995 million.

For the nine months ended September 30, 2024, the Company issued the following:

•On September 18, 2024, issuance of US$750 million ($1,020 million) 4.38% Notes due 2034 in the U.S. capital markets, which resulted in total net proceeds of $1,011 million; and

•On May 2, 2024, issuance of $700 million 4.60% Notes due 2029 and $550 million 5.10% Notes due in 2054 in the Canadian capital markets, which resulted in total net proceeds of $1,242 million.

Revolving credit facilities

On March 28, 2025, the Company's revolving credit facility agreements were amended to extend their respective tenors by one additional year each. The unsecured credit facility of $2.5 billion consists of two tranches of $1.25 billion and are now maturing on March 31, 2028 and March 31, 2030, respectively. The unsecured credit facility of $1.0 billion is now maturing on March 17, 2027. The credit facilities provide borrowings at various benchmark interest rates, such as the Secured Overnight Financing Rate (SOFR) and the Canadian Overnight Repo Rate Average (CORRA), plus applicable margins, based on CN's credit ratings. Both revolving credit facility agreements have one financial covenant, which limits debt as a percentage of total capitalization. The Company is in compliance as at September 30, 2025.

As at September 30, 2025 and December 31, 2024, the Company had no outstanding borrowings under these revolving credit facilities and there were no draws during the nine months ended September 30, 2025.

Equipment loans

Borrowings under the non-revolving term loan facilities are provided at SOFR or CORRA plus applicable margins.

During the first nine months of 2025, the Company repaid $66 million of its equipment loans. As at September 30, 2025 and December 31, 2024, the Company had outstanding borrowings of $1,360 million and $1,449 million, respectively, at a weighted-average interest rate of 4.21% and 4.79%, respectively.

Commercial paper

As at September 30, 2025 and December 31, 2024 , the Company had total commercial paper borrowings of US$557 million ($776 million) and US$501 million ($721 million) respectively, at a weighted-average interest rate of 4.31% and 4.73% respectively, presented in Current portion of long-term debt on the Consolidated Balance Sheets.

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Commercial paper with maturities less than 90 days
Issuance	$	6,979	$	5,398	$	18,236	$	12,774
Repayment	(6,260)		(5,519)		(17,986)		(13,327)
Change in commercial paper with maturities less than 90 days, net	$	719	$	(121)	$	250	$	(553)
Commercial paper with maturities of 90 days or greater
Issuance	$	—	$	—	$	—	$	1,472
Repayment	—		(554)		(224)		(1,675)
Change in commercial paper with maturities of 90 days or greater, net	$	—	$	(554)	$	(224)	$	(203)
Change in commercial paper, net	$	719	$	(675)	$	26	$	(756)

22 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

Accounts receivable securitization program

On March 28, 2025, the Company extended the term of its agreement by one year to February 2, 2027. As at September 30, 2025 and December 31, 2024, the Company had no outstanding borrowings under the accounts receivable securitization program and there were no draws during the nine months ended September 30, 2025.

Bilateral letter of credit facilities

On March 28, 2025, the Company extended the maturity date of its committed bilateral letter of credit facility agreements to April 28, 2028.

As at September 30, 2025, the Company had outstanding letters of credit of $322 million ($329 million as at December 31, 2024) under the committed facilities and $153 million ($142 million as at December 31, 2024) under the uncommitted facilities.

Repurchase of common shares

The Company may repurchase its common shares pursuant to a Normal Course Issuer Bid (NCIB) at prevailing market prices plus brokerage fees, or such other prices as may be permitted by the Toronto Stock Exchange. Under its current NCIB, the Company may repurchase up to 20.0 million common shares between February 4, 2025 and February 3, 2026. As at September 30, 2025, the Company had repurchased 9.9 million common shares for $1,321 million under its current NCIB.

As at September 30, 2025, the Company had accrued a liability of $27 million for the two percent tax on net share repurchases made in the first nine months of 2025 ($51 million as at December 31, 2024), which was accounted for as a direct cost of common share repurchases and recorded in Shareholders’ equity. The accrued tax obligation for the 2024 net share repurchases was paid in the first quarter of 2025.

The Company repurchased 13.9 million common shares under its previous NCIB, including 0.6 million common shares in the first quarter of 2025, which allowed for the repurchase of up to 32.0 million common shares between February 1, 2024 and January 31, 2025.

	Three months ended September 30				Nine months ended September 30
In millions, except per share data	2025		2024		2025		2024
Number of common shares repurchased	7.7		2.5		10.5		14.4
Weighted-average price per share (1)	$	134.77	$	165.40	$	137.91	$	172.96
Amount of repurchase (1)(2)	$	1,041	$	427	$	1,448	$	2,498

(1)Includes brokerage fees and tax on share repurchases.

(2)Includes settlements in subsequent periods.

CN| 2025 Quarterly Review – Third Quarter 23

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

9 – Stock-based compensation

The Company has various stock-based compensation plans for eligible employees. A description of the major plans is provided in Note 19 –Stock-based compensation to the Company's 2024 Annual Consolidated Financial Statements.

	Three months ended September 30				Nine months ended September 30
In millions	2025		2024		2025		2024
Share Units Plan (1)	$	13	$	(6)	$	50	$	26
Voluntary Incentive Deferral Plan (VIDP) (2)	—		—		—		1
Stock option awards	2		3		9		9
Employee Share Investment Plan (ESIP)	8		7		23		21
Total stock-based compensation expense	$	23	$	4	$	82	$	57
Income tax impacts of stock-based compensation
Tax benefit recognized in income	$	7	$	1	$	21	$	14
Net excess tax benefit (deficiency) recognized in income	$	—	$	—	$	(6)	$	15

(1)Performance share unit (PSU) awards and restricted share unit (RSU) awards are granted under the Share Units Plan. PSU-ROIC awards and PSU-TSR awards settle depending on the level of attainment of a target return on invested capital (ROIC) performance condition, and on the level of attainment of a target total shareholder return (TSR) market condition, respectively, as defined by the award agreement, over the plan period of three years. RSU awards settle depending on continued employment throughout the plan period, and are not subject to market or performance conditions.

(2)Deferred share unit (DSU) awards are granted under the Voluntary Incentive Deferral Plan.

Share Units Plan

	PSUs-ROIC (1)			PSUs-TSR (2)			RSUs (3)
	Units	Weighted-average grant date fair value		Units	Weighted-average grant date fair value		Units	Weighted-average grant date fair value
	In millions			In millions			In millions
Outstanding at December 31, 2024	0.4	$	123.77	0.4	$	192.33	0.2	$	157.55
Granted (4)	0.3	$	143.41	0.1	$	187.06	0.3	$	143.89
Settled (5)	—	$	—	(0.1)	$	179.03	—	$	—
Forfeited	—	$	123.45	—	$	189.14	—	$	146.44
Outstanding at September 30, 2025	0.7	$	131.14	0.4	$	191.68	0.5	$	147.87

(1)The grant date fair value of equity settled PSU-ROIC awards granted in 2025 of $36 million is valued based on the closing share price of the Company's stock on the date of the grant. As at September 30, 2025, total unrecognized compensation cost related to all outstanding awards was $16 million and is expected to be recognized over a weighted-average period of 2.2 years.

(2)The grant date fair value of equity settled PSU-TSR awards granted in 2025 of $30 million is calculated using a Monte Carlo simulation model. As at September 30, 2025, total unrecognized compensation cost related to all outstanding awards was $30 million and is expected to be recognized over a weighted-average period of 1.9 years.

(3)The grant date fair value of equity settled RSU awards granted in 2025 of $50 million is valued based on the closing share price of the Company's stock on the date of the grant. As at September 30, 2025, total unrecognized compensation cost related to all outstanding awards was $36 million and is expected to be recognized over a weighted-average period of 1.6 years.

(4)Units granted in lieu of dividends have not been quantified as they relate to a nominal amount of units.

(5)Equity settled PSU-TSR awards granted in 2022 attained a performance vesting factor of 50%. In the first quarter of 2025, these awards were settled, net of the remittance of the participants' withholding tax obligation of $4 million, by way of disbursement from the Share Trusts of a nominal number of common shares.

24 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

Voluntary Incentive Deferral Plan

	DSUs (1)
	Units	Weighted-average grant date fair value
	In millions
Outstanding at December 31, 2024	0.3	$	120.55
Granted	—	$	147.94
Settled	—	$	122.68
Outstanding at September 30, 2025 (2)	0.3	$	122.26

(1)The grant date fair value of equity settled DSU awards granted in 2025 of $3 million is calculated using the Company's stock price on the grant date. As at September 30, 2025, the aggregate intrinsic value of all equity settled DSU awards outstanding amounted to $39 million.

(2)The total fair value of equity settled DSU awards vested, the number of units outstanding that were nonvested, unrecognized compensation cost and the remaining recognition period, and the withholding tax obligation remitted on the settlement of DSU awards have not been quantified as they relate to a nominal number of units.

Stock option awards

	Options outstanding
	Number of options	Weighted-average exercise price
	In millions
Outstanding at December 31, 2024 (1)	3.2	$	142.55
Granted (2)	0.6	$	143.24
Exercised	(0.4)	$	117.01
Forfeited	(0.1)	$	154.73
Outstanding at September 30, 2025 (1)(2)(3)	3.3	$	141.95
Exercisable at September 30, 2025 (1)(3)	1.9	$	134.15

(1)Stock options with a US dollar exercise price have been translated into Canadian dollars using the foreign exchange rate in effect at the balance sheet date.

(2)The grant date fair value of options granted in 2025 of $15 million ($26.39 per option) is calculated using the Black-Scholes option-pricing model. As at September 30, 2025, total unrecognized compensation cost related to all outstanding awards was $23 million and is expected to be recognized over a weighted-average period of 2.5 years.

(3)The weighted-average term to expiration of options outstanding was 6.1 years and the weighted-average term to expiration of exercisable stock options was 4.8 years. As at September 30, 2025, the aggregate intrinsic value of in-the-money stock options outstanding amounted to $17 million and the aggregate intrinsic value of stock options exercisable amounted to $17 million.

Employee Share Investment Plan

	ESIP
	Number of shares	Weighted-average share price
	In millions
Unvested contributions at December 31, 2024	0.2	$	163.25
Company contributions	0.2	$	140.06
Forfeited	—	$	146.72
Vested (1)	(0.1)	$	166.89
Unvested contributions at September 30, 2025 (2)	0.3	$	142.75

(1)As at September 30, 2025, total fair value of units purchased with Company contributions that vested in 2025 was $20 million.

(2)As at September 30, 2025, total unrecognized compensation cost related to all outstanding awards was $18 million and is expected to be recognized over the next 12 months.

CN| 2025 Quarterly Review – Third Quarter 25

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

10 – Accumulated other comprehensive loss

The following tables present the changes in Accumulated other comprehensive loss by component for the three and nine months ended September 30, 2025 and 2024:

In millions	Foreign  currency  translation		Pension  and other postretirement benefit plans		Derivative instruments		Total  before tax		Income tax recovery (expense) (1)		Total  net of tax
Balance at June 30, 2025	$	(128)	$	(1,955)	$	82	$	(2,001)	$	572	$	(1,429)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)	385						385		—		385
Translation of US dollar debt (3)	(248)						(248)		33		(215)
Derivative instruments (4)					33		33		(5)		28
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)			14				14		(4)		10
Amortization of prior service credit			(1)				(1)		1		—
Amortization of derivative instruments (6)					(36)		(36)		6		(30)
Other comprehensive income (loss)	137		13		(3)		147		31		178
Balance at September 30, 2025	$	9	$	(1,942)	$	79	$	(1,854)	$	603	$	(1,251)

In millions	Foreign  currency  translation		Pension  and other postretirement benefit plans		Derivative instruments		Total  before tax		Income tax recovery (expense) (1)		Total  net of tax
Balance at December 31, 2024	$	217	$	(1,978)	$	79	$	(1,682)	$	662	$	(1,020)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)	(586)						(586)		—		(586)
Translation of US dollar debt (3)	378						378		(51)		327
Derivative instruments (4)					(31)		(31)		3		(28)
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)			39				39		(9)		30
Amortization of prior service credit			(3)				(3)		1		(2)
Amortization of derivative instruments (6)					31		31		(3)		28
Other comprehensive income (loss)	(208)		36		—		(172)		(59)		(231)
Balance at September 30, 2025	$	9	$	(1,942)	$	79	$	(1,854)	$	603	$	(1,251)

Footnotes to the tables follow on the next page.

26 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

In millions	Foreign  currency  translation		Pension  and other postretirement benefit plans		Derivative instruments		Total  before tax		Income tax recovery (expense)(1)		Total  net of tax
Balance at June 30, 2024	$	(23)	$	(2,976)	$	96	$	(2,903)	$	839	$	(2,064)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)	(186)						(186)		—		(186)
Translation of US dollar debt (3)	133						133		(17)		116
Derivative instruments (4)					(15)		(15)		4		(11)
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)			14				14		(4)		10
Amortization of prior service credit			(2)				(2)		—		(2)
Amortization of gain on treasury locks					(1)		(1)		—		(1)
Other comprehensive income (loss)	(53)		12		(16)		(57)		(17)		(74)
Balance at September 30, 2024	$	(76)	$	(2,964)	$	80	$	(2,960)	$	822	$	(2,138)

In millions	Foreign  currency  translation		Pension  and other postretirement benefit plans		Derivative instruments		Total  before tax		Income tax recovery (expense)(1)		Total  net of tax
Balance at December 31, 2023	$	(171)	$	(3,003)	$	99	$	(3,075)	$	796	$	(2,279)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)	332						332		—		332
Translation of US dollar debt (3)	(237)						(237)		32		(205)
Derivative instruments (4)					(15)		(15)		4		(11)
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)			42				42		(11)		31
Amortization of prior service credit			(3)				(3)		—		(3)
Amortization of gain on treasury locks					(4)		(4)		1		(3)
Other comprehensive income (loss)	95		39		(19)		115		26		141
Balance at September 30, 2024	$	(76)	$	(2,964)	$	80	$	(2,960)	$	822	$	(2,138)

(1)The Company releases stranded tax effects from Accumulated other comprehensive loss to Net income upon the liquidation or termination of the related item.

(2)Foreign exchange gain (loss) on translation of net investment in foreign operations.

(3)Foreign exchange gain (loss) on translation of US dollar-denominated debt designated as a hedge of the net investment in foreign operations. The Company designates US dollar-denominated debt of the parent company as a foreign currency hedge of its net investment in foreign operations. Accordingly, from the dates of designation, foreign exchange gains and losses on translation of the Company's US dollar-denominated debt are recorded in Accumulated other comprehensive loss, which minimizes the volatility of earnings resulting from the conversion of US dollar-denominated debt into Canadian dollars.

(4)The cumulative changes in fair values of cross-currency interest rate swaps and the cumulative gains or losses of treasury locks are included in Derivative instruments. See Note 12 – Financial instruments.

(5)Total before tax reclassified to Other components of net periodic benefit income in the Consolidated Statements of Income and included in net periodic benefit income. See Note 6 – Pensions and other postretirement benefits for additional information.

(6)Includes the amortization of treasury locks for the three months and nine months ended September 30, 2025 of $1 million and $3 million, respectively, as well as the amortization of cross-currency interest rate swaps related to foreign currency exposure and interest expense. See Note 12 - Financial instruments.

CN| 2025 Quarterly Review – Third Quarter 27

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

11 – Major commitments and contingencies

Purchase commitments

As at September 30, 2025, the Company had fixed and variable commitments to purchase information technology services and licenses, rail, engineering services, locomotives, wheels, railroad cars, rail ties, as well as other equipment and services with a total estimated cost of $2,355 million. Costs of variable commitments were estimated using forecasted prices and volumes.

Contingencies

In the normal course of business, the Company becomes involved in various legal actions seeking compensatory and occasionally punitive damages, including actions brought on behalf of various purported classes of claimants and claims relating to employee and third-party personal injuries, occupational disease and property damage, arising out of harm to individuals or property allegedly caused by, but not limited to, derailments or other accidents.

As at September 30, 2025, the Company had aggregate reserves for personal injury and other claims of $265 million, of which $43 million was recorded as a current liability ($284 million as at December 31, 2024, of which $47 million was recorded as a current liability).

Although the Company considers such provisions to be adequate for all its outstanding and pending claims, the final outcome with respect to actions outstanding or pending as at September 30, 2025, or with respect to future claims, cannot be reasonably determined. When establishing provisions for contingent liabilities the Company considers, where a probable loss estimate cannot be made with reasonable certainty, a range of potential probable losses for each such matter, and records the amount it considers the most reasonable estimate within the range. However, when no amount within the range is a better estimate than any other amount, the minimum amount in the range is accrued. For matters where a loss is reasonably possible but not probable, a range of potential losses cannot be estimated due to various factors which may include the limited availability of facts, the lack of demand for specific damages and the fact that proceedings were at an early stage. Based on information currently available, the Company believes that the eventual outcome of the actions against the Company will not, individually or in the aggregate, have a material adverse effect on the Company's financial position. However, due to the inherent inability to predict with certainty unforeseeable future developments, there can be no assurance that the ultimate resolution of these actions will not have a material adverse effect on the Company's results of operations, financial position or liquidity.

Environmental matters

The Company's provision for specific environmental sites is undiscounted and includes costs for remediation and restoration of sites, as well as monitoring costs. Costs related to any unknown existing or future contamination will be accrued in the period in which they become probable and reasonably estimable. Additional information relating to the Company's environmental matters is provided in Note 21 – Major commitments and contingencies to the Company's 2024 Annual Consolidated Financial Statements.

Under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA), the Company through one of its subsidiaries was notified by the U.S. Environmental Protection Agency (EPA) on February 28, 2024 that the EPA considers it a potentially responsible party (PRP), along with at least five other previously notified parties, with respect to the Matthiessen & Hegeler Zinc Company Site (Site) in LaSalle, Illinois. The EPA also requested that the Company respond to certain information requests, which the Company did on June 30, 2024. The Company’s designation as a PRP is based on claims that the Company, or its predecessors, had land holdings historically that were leased to others for commercial or industrial uses that may allegedly have resulted in the disposal of hazardous substances onto the Site. Based on remedial investigations and feasibility studies previously conducted, the EPA issued a Record of Decision outlining the clean-up plan for the Site and certain off-Site areas. In the second quarter of 2025, CN received a special notice letter from the EPA which requests CN to respond with a good faith offer by August 4, 2025. The Company responded to the EPA on August 4, 2025 reiterating why it should not be considered a PRP for the Site and as at October 30, 2025, there have been no further developments. The Company has not accrued for any obligation related to the remediation of the Site as it has not been able to confirm to what, if any, extent it contributed to the contamination, the extent and cost of remediation and the contribution of other potentially responsible parties and their ability to pay for their obligations.

For matters where a loss is reasonably possible but not probable, a range of potential losses cannot be estimated due to various factors which may include the limited availability of facts, the lack of demand for specific damages and the fact that proceedings were at an early stage.

28 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

As at September 30, 2025, the Company had aggregate accruals for environmental costs of $63 million, of which $39 million was recorded as a current liability ($56 million as at December 31, 2024, of which $40 million was recorded as a current liability). The Company anticipates that the liability at September 30, 2025 will be paid out over the next five years. Based on the information currently available, the Company considers its accruals to be adequate.

Guarantees and indemnifications

A description of the Company's guarantees and indemnifications is provided in Note 21 – Major commitments and contingencies to the Company's 2024 Annual Consolidated Financial Statements.

As at September 30, 2025, the Company had outstanding letters of credit of $322 million ($329 million as at December 31, 2024) under the committed bilateral letter of credit facilities and $153 million ($142 million as at December 31, 2024) under the uncommitted bilateral letter of credit facilities, and surety and other bonds of $148 million ($145 million as at December 31, 2024), all issued by financial institutions with investment grade credit ratings to third parties to indemnify them in the event the Company does not perform its contractual obligations.

As at September 30, 2025, the maximum potential liability under these guarantee instruments was $623 million ($616 million as at December 31, 2024), of which $582 million ($571 million as at December 31, 2024) related to other employee benefit liabilities and workers' compensation and $41 million ($45 million as at December 31, 2024) related to other liabilities. The guarantee instruments expire at various dates between 2025 and 2027.

As at September 30, 2025, the Company had not recorded a liability with respect to guarantees and indemnifications as the Company did not expect to make any payments under its guarantees and indemnifications.

12 – Financial instruments

Derivative financial instruments

The Company uses derivative financial instruments from time to time in the management of its foreign currency and interest rate exposures. The Company has limited involvement with derivative financial instruments in the management of its risks and does not hold or issue them for trading or speculative purposes.

Foreign currency risk

Foreign exchange forward contracts

As at September 30, 2025, the Company had outstanding foreign exchange forward contracts to purchase as notional value of US$557 million (US$580 million as at December 31, 2024). These outstanding contracts are at a weighted-average exchange rate of $1.38 per US$1.00 ($1.37 per US$1.00 as at December 31, 2024). The weighted-average term of the contracts is 39 days (88 days as at December 31, 2024). Changes in fair values of foreign exchange forward contracts, resulting from changes in foreign exchange rates, are recognized in Other income in the Consolidated Statements of Income as they occur.

For the three and nine months ended September 30, 2025, the Company recorded a gain of $40 million and a loss of $7 million, respectively, related to foreign exchange forward contracts compared to a loss of $22 million and a gainof $53 million, respectively, for the same periods in 2024. These gains were largely offset by the re-measurement of US dollar-denominated monetary assets and liabilities recorded in Other income.

As at September 30, 2025,the fair value of outstanding foreign exchange forward contracts included in Other current assets was $7million ($38 million, as at December 31, 2024).

CN| 2025 Quarterly Review – Third Quarter 29

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

Cross-currency interest rate swaps

As at September 30, 2025, the aggregate notional amount of cross-currency interest rate swaps entered into was US$975 million to hedge the US-to-Canadian dollar currency fluctuations on US dollar-denominated notes maturing on March 1, 2026 and July 15, 2028, for an aggregate principal amount of $1,401 million with a weighted average fixed annual interest rate of 3.33%.

These cross-currency interest rate swaps were designated as qualifying hedging instruments and were accounted for as cash flow hedges, with their critical terms corresponding to the related US dollar-denominated notes.

For the three and nine months ended September 30, 2025, the cumulative changes in fair values of these cross-currency interest rate swaps recorded in Accumulated other comprehensive loss in derivative instruments resulted in a gain of $32 million and a loss of $33 million, respectively. For the three and nine months ended September 30, 2025, the amounts amortized from Accumulated other comprehensive income to Other income related to foreign currency exposure and Interest expense were gains of $31 million and $4 million respectively, and a loss of $44 million and a gain of $10 million, respectively, in the same period that the carrying values of the two US dollar-denominated notes were remeasured to Canadian dollars and the interest expense was recognized.

As at September 30, 2025, the fair value of outstanding cross-currency interest rate swaps included in Other current asset was $9 million, Accounts payable and other was $22 million and Other liabilities and deferred credits was $27 million.

The cash flows related to these cross-currency interest rate swaps that pertain to the periodic interest settlements are classified as operating activities and the cash flows that pertain to the principal balance will be classified as financing activities.

Interest rate risk

Treasury locks

As at September 30, 2025, the aggregate notional amount of treasury lock agreements entered into was US$400 million to hedge US Treasury benchmark rates related to an upcoming debt issuance. The treasury locks are designated as cash flow hedging instruments with cumulative gains or losses recorded in Accumulated other comprehensive loss in derivative instruments. The treasury locks will be settled upon the issuance of debt at which point the cumulative gains or losses recorded in Accumulated other comprehensive loss will be amortized in earnings as a reduction or increase of interest expense over the term of the corresponding debt.

For the three and nine months ended September 30, 2025, the cumulative change in fair value of these treasury locks recorded in Accumulated other comprehensive loss in derivative instruments resulted in gains of $1 million and $2 million, respectively.

As at September 30, 2025, the fair value of outstanding treasury lock agreements included in Other current assets was $3 million and Other current liabilities was $1 million.

Interest rate swaps

As at September 30, 2025, the Company had outstanding swaps with a notional amount of $1.0 billion designated as qualifying hedging instruments and accounted for as fair value hedges on a cumulative $1.0 billion of notes maturing on June 10, 2030 and June 10, 2035. The swaps were designed to hedge the interest rate risk associated with market fluctuations attributable to the Canadian Overnight Repo Rate Average (CORRA). The fair value gain or loss on the swaps as well as any offsetting loss or gain on the hedged notes attributable to the hedged risk are recorded in Interest expense.

For the three and nine months ended September 30, 2025, the cumulative change in fair value of these swaps recorded in Other current assets and Intangible assets, goodwill and other resulted in gains of $7 million and $5 million, respectively. For the three and nine months ended September 30, 2025, the hedging adjustment included in the carrying amount of the hedged notes within Long-term debt was losses of $7 million and $5 million, respectively.

Periodic net interest accruals for these swaps are recorded in Interest expense which were nominal for the three and nine months ended September 30, 2025, and their related settlements will be included as part of cash flows from operating activities.

30 CN| 2025 Quarterly Review – Third Quarter

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

Fair value of financial instruments

The financial instruments that the Company measures at fair value on a recurring basis in periods subsequent to initial recognition are categorized into the following levels of the fair value hierarchy based on the degree to which inputs are observable:

•Level 1: Inputs are quoted prices for identical instruments in active markets

•Level 2: Significant inputs (other than quoted prices included in Level 1) are observable

•Level 3: Significant inputs are unobservable

The carrying amounts of Cash and cash equivalents and Restricted cash and cash equivalents approximate fair value. These financial instruments include highly liquid investments purchased three months or less from maturity, for which the fair value is determined by reference to quoted prices in active markets.

The carrying amounts of Accounts receivable, Other current assets and Accounts payable and other approximate fair value due to their short maturity, unless otherwise specified. The fair value of derivative financial instruments, included in Other current assets and Accounts payable and other is classified as Level 2 and is used to manage the Company's exposure to foreign currency risk and interest rate risk. The fair value is measured by discounting future cash flows using a discount rate derived from market data for financial instruments subject to similar risks and maturities.

The carrying amount of the Company's debt does not approximate fair value. The fair value is estimated based on quoted market prices for the same or similar debt instruments, as well as discounted cash flows using current interest rates for debt with similar terms, company rating, and remaining maturity. The Company classifies debt as Level 2. As at September 30, 2025, the Company's debt, excluding finance leases, had a carrying amount of $21,114 million ($20,887 million as at December 31, 2024) and a fair value of $20,147 million ($19,688 million as at December 31, 2024). The carrying amount of debt excluding finance leases exceeded the fair value due to market rates being higher than the stated coupon rates.

13 – Segmented information

As at December 31, 2024, the Company has adopted ASU 2023-07 Segment reporting (Topic 280): Improvements to reportable segment disclosures. Additional details relating to the Company's segmented information is provided in Note 23 - Segment information to the Company's 2024 Annual Consolidated Financial Statements.

Net income and diluted earnings per share (EPS), which are reported on the Company's Consolidated Statements of Income, are the profit measures reviewed by the Chief Operating Decision Maker (CODM). These measures are used by the CODM to assess segment profitability, allocate resources across CN's network, benchmark performance against targets and industry standards, analyze trends for strategic planning and forecasting and communicating results to stakeholders.

Significant segment expenses regularly provided to the CODM and included within net income and EPS are the expense captions detailed in the Consolidated Statements of Income. The measure of segment assets is reported on the Consolidated Balance Sheets as Total assets. Segment property additions is reported on the Consolidated Statements of Cash Flows as Property additions.

CN| 2025 Quarterly Review – Third Quarter 31